Mitchell Shirvan, CSO and CDO at Silexion Therapeutics Corp (SLXN), sold 22,818 shares at $1.36 ($31K) on 2026-03-26, disclosed to the SEC on 2026-03-30.
Open-market sale of $31k SLXN by CSO and CDO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.